Pharmaceuticals (9) | Investment Agreements (9)

Browse by Company

Recent Contracts

Equity Commitment and Investment Agreement dated March 8, 2021 by and between ANI Pharmaceuticals, Inc. and Ampersand 2020 Limited Partnership (ANI Pharma Inc, Filed With SEC on March 9, 2021)
Investment Banking Agreement (WEED, INC., Filed With SEC on March 8, 2021)
Letter Agreement, dated June 30, 2020, among the Company, the Sponsor, Cowen Investments and the Companys officers and directors (Panacea Acquisition Corp, Filed With SEC on July 6, 2020)
Form of Letter Agreement among the Registrant and the Registrants officers and directors, EcoR1 Panacea Holdings, LLC and Cowen Investments II LLC (Panacea Acquisition Corp, Filed With SEC on June 23, 2020)
Securities Subscription Agreement, dated May 7, 2020, between the Registrant and Cowen Investments II LLC (Panacea Acquisition Corp, Filed With SEC on June 12, 2020)
Investment and Royalty Agreement, dated March 12, 2018 by and between Aron Funds, LLC and EWSD I LLC (Notis Global, Inc., Filed With SEC on November 27, 2019)
Agreement, dated March 25, 2019, by and among Recro Pharma, Inc., Engine Capital, L.P., Engine Jet Capital, L.P., Engine Investments, LLC, and Arnaud Ajdler (Recro Pharma, Inc., Filed With SEC on March 28, 2019)
Investment Agreement between Australis Capital Inc. and Body and Mind Inc., dated January 31, 2019 (BODY & MIND INC., Filed With SEC on February 6, 2019)
Investment Agreement, dated January 15, 2019, by and among Lexaria Bioscience Corp., Lexaria Nicotine LLC, PoViva Corp. and Altria Ventures Inc (Lexaria Bioscience Corp., Filed With SEC on January 22, 2019)